Sign In
Buy FOLD
$14.49
+0 (+0%)
At Close: Jun 03, 2026
Vaccines trials in the COVID-19 era and tech's role in speeding studies -
03:54pm, Wednesday, 25'th Mar 2020
The COVID-19 outbreak has exposed the challenges pharmaceutical companies face as they race to develop a coronavirus vaccine.
Amicus Therapeutics, Inc. (NASDAQ:FOLD) CEO Sells $180,000.00 in Stock
10:44am, Wednesday, 25'th Mar 2020
Amicus Therapeutics, Inc. (NASDAQ:FOLD) CEO John F. Crowley sold 20,000 shares of the business’s stock in a transaction dated Friday, March 20th. The shares were sold at an average price of $9.00, f
Amicus Therapeutics (NASDAQ:FOLD) Upgraded to "Buy" by BidaskClub
07:40am, Wednesday, 25'th Mar 2020
Amicus Therapeutics (NASDAQ:FOLD) was upgraded by research analysts at BidaskClub from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday, BidAskClub reports
Edited Transcript of FOLD earnings conference call or presentation 2-Mar-20 1:30pm GMT
02:00pm, Tuesday, 24'th Mar 2020
Q4 2019 Amicus Therapeutics Inc Earnings Call
AlphaCrest Capital Management LLC Buys 4,973 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD)
10:00am, Tuesday, 24'th Mar 2020
AlphaCrest Capital Management LLC lifted its stake in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) by 27.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC
Amicus says global supply chains for Galafold have not been interrupted FOLD
11:15am, Monday, 23'rd Mar 2020
Amicus says global supply chains for Galafold have not been interrupted FOLD
Amicus Therapeutics (FOLD), a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, today announced that the Company has
CRANBURY, N.J., March 23, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a global, patient-dedicated biotechnology company focused on...
Amicus Therapeutics Confirms Business Continuity, —…—… Strategic Priorities and ...
12:00am, Monday, 23'rd Mar 2020Edited Transcript of FOLD earnings conference call or presentation 2-Mar-20 1:30pm GMT
07:31pm, Sunday, 22'nd Mar 2020
Q4 2019 Amicus Therapeutics Inc Earnings Call
5 Absurdly Cheap Biotech Stocks That Could Make You Filthy Rich
01:40pm, Sunday, 22'nd Mar 2020
These five biotech stocks could post life-changing gains for early-bird investors.
Banco Bilbao Vizcaya Argentaria S.A. Buys Shares of 25,000 Amicus Therapeutics, Inc. (NASDAQ:FOLD)
09:00am, Sunday, 22'nd Mar 2020
Banco Bilbao Vizcaya Argentaria S.A. acquired a new position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) in the 4th quarter, according to the company in its most recent Form 13F filing with t
Mayor Bill de Blasio: Musk Offered to Make Ventilators, So Let's See 'Em
06:00pm, Thursday, 19'th Mar 2020
Late last night, Elon Musk promised a fan that Tesla “will make ventilators if there is a shortage.” Several hours later, Mayor Bill de Blasio confirmed that there is a national shortage, took him
Crypto-Based Lolli Struggles to Keep Up with Demand
07:00pm, Tuesday, 17'th Mar 2020
Companies like Lolli say they cannot keep up with the amount of bitcoin payments they've been asked to process over the past month.
ProShare Advisors LLC Reduces Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD)
10:48am, Tuesday, 17'th Mar 2020
ProShare Advisors LLC cut its holdings in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) by 8.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 89,788 shares of the biopharmac
